FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/10/037274 [Registered on: 12/10/2021] Trial Registered Prospectively
Last Modified On: 10/10/2021
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   COMPARITIVE STUDY BETWEEN DEXMEDETOMEDINE AND BUPRENORPHINE AS AN ADJUVANT TO ROPIVACAINE 0.5% IN ULTRASOUND GUIDED SUPRACLAVICULAR BRACHIAL PLEXUS BLOCK FOR UPPER LIMB ORTHOPEDIC SURGERIES  
Scientific Title of Study   A PROSPECTIVE RANDOMIZED, COMPARITIVE STUDY BETWEEN DEXMEDETOMEDINE AND BUPRENORPHINE AS AN ADJUVANT TO ROPIVACAINE 0.5% IN ULTRASOUND GUIDED SUPRACLAVICULAR BRACHIAL PLEXUS BLOCK FOR UPPER LIMB ORTHOPEDIC SURGERIES  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sangeetha C 
Designation  Assistant Professor 
Affiliation  Sanjay Gandhi Institute of Trauma And Orthopedics 
Address  Department of Anesthesia Sanjay Gandhi Institute Of Trauma And Orthopedics Byrasandra Jayanagar Bengaluru
Sanjay Gandhi Institute Of Trauma And Orthopedics Byrasandra Jayanagar Bengaluru
Bangalore
KARNATAKA
560011
India 
Phone  9886623479  
Fax    
Email  sangudaya.sd@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sangeetha C 
Designation  Assistant Professor 
Affiliation  Sanjay Gandhi Institute of Trauma And Orthopedics 
Address  Department of Anesthesia Sanjay Gandhi Institute Of Trauma And Orthopedics Byrasandra Jayanagar Bengaluru
Sanjay Gandhi Institute Of Trauma And Orthopedics Byrasandra Jayanagar Bengaluru
Bangalore
KARNATAKA
560011
India 
Phone  9886623479  
Fax    
Email  sangudaya.sd@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sangeetha C 
Designation  Assistant Professor 
Affiliation  Sanjay Gandhi Institute of Trauma And Orthopedics 
Address  Department of Anesthesia Sanjay Gandhi Institute Of Trauma And Orthopedics Byrasandra Jayanagar Bengaluru
Sanjay Gandhi Institute Of Trauma And Orthopedics Byrasandra Jayanagar Bengaluru
Bangalore
KARNATAKA
560011
India 
Phone  9886623479  
Fax    
Email  sangudaya.sd@gmail.com  
 
Source of Monetary or Material Support  
Sanjay Gandhi Institute Of Trauma And Orthopedics 
 
Primary Sponsor  
Name  Sanjay Gandhi Institute Of Trauma And Orthopedics 
Address  Sanjay Gandhi Institute Of Trauma And Orthopedics, Byrasandra, Jayanagar, Bengaluru 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sangeetha C  Major operation theater Sanjay Gandhi Institute of Trauma and Orthopedics  Sanjay Gandhi Institute Of Trauma And Orthopedics Byrasandra jayanagar Bengaluru
Bangalore
KARNATAKA 
9886623479

sangudaya.sd@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 2  
Name of Committee  Approval Status 
Sanjay Gandhi Institute Of Trauma And Orthopaedics  Approved 
Sanjay Gandhi institute Of Trauma And Orthopedics  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: S521||Fracture of upper end of radius, (2) ICD-10 Condition: S520||Fracture of upper end of ulna,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  buprenorphine  buprenorphine 3mcg/kg at the time of block administration 
Comparator Agent  dexmedetomidine   dexmedetomidine 1mcg/kg at the time of block administration 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients aged between 18 to 60 years admitted for elective upperlimb orthopaedic surgeries in Sanjay Gandhi Institute Of Trauma And Orthopaedics,Bengaluru
 
 
ExclusionCriteria 
Details  History of neurological, psychiatric, neuromuscular,alcoholism or drug abuse and patients receiving adrenoceptor agonist or antagonist therapy.

 
 
Method of Generating Random Sequence   Random Number Table 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
time of onset of sensory block and duration of analgesia  1 day 
 
Secondary Outcome  
Outcome  TimePoints 
any adverse effects  1 day 
 
Target Sample Size   Total Sample Size="90"
Sample Size from India="90" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   21/10/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
.Supraclavicular block is a regional anaesthetic technique used as an alternative or adjunct to general anesthesia or used for postoperative pain control for upper extremity surgeries (mid-humerus through the hand).
Various adjuvants have been added to local anesthetics to increase the efficacy and duration of blocks,minimizing systemic adverse effects along with a reduction in the total dose of local anesthetic used.
Dexmedetomidine, a potent α2 adrenocepter agonist ,has been reported to improve the quality of intrathecal and epidural anesthesia.(1,2,3) Its use in peripheral nerve blocks has recently been described.
Buprenorphine is lipophilic opioid with high molecular weight and having high affinity for μ receptors, has a longer duration of action,and is easily available, cost-effective and hence selected for this study
Ropivacaine has a long duration of action, with similar pharmacology to bupivacaine but a wider safety margin
In this study, we will investigate whether adding dexmedetomidine  or buprenorphine to 0.5%ropivacaine for supraclavicular brachial plexus block would affect the sensory and motor blocks and duration of analgesia

 
Close